Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Na&#239;ve Patients with Perianal Fistulizing Crohn&#39;s Disease: A Prospective, Single-Arm, Observational Study.

Anjianning (adalimumab biosimilar) - Zhejiang Hisun Pharmaceutical

http://www.ncbi.nlm.nih.gov/pubmed/41939432

Huan Wang; Jiamin Li; Junrong Li; Liangru Zhu; Liu Fang; Qi Yu; Xiaopeng Zhang; Xiaoyu Fu; Yidong Chen; Yiyu Cheng

Apr 6, 2026